While IL-6 and IL-1 play central roles in CAR T cell-induced CRS, high levels of IFNγ are also observed (177), and any cytokine that enhances IFNγ production by CAR T cells or other immune cells could potentially increase the incidence and/or severity of CRS. This evidence concerns the gene IL1A and congenital rubella syndrome.